Growth, engagement, and impact — Q3 shows the difference on-demand cancer care can make.
→ 91% of symptom management interactions are resolved by RC without escalation to partner providers.
→ 89% patient engagement at 6 months.
→ 9.2/10 overall provider satisfaction.
→ 9/10 patient satisfaction.
Q3 wasn’t just another strong quarter. It was proof.
Proof that cancer care can be delivered at home without compromising quality. Proof that patients will engage when care meets them where they are. Proof that clinicians can be empowered instead of overwhelmed.
“These results reflect what happens when we combine empathy with innovation,” said Dan Nardi, CEO. “We’re not just reducing unnecessary visits or saving clinician time. We’re changing the experience of cancer itself.”
Our partners are showing the industry what connected, proactive, on-demand oncology looks like—and the results speak for themselves.
📊 Explore the full Q3 Impact Report to see how growth, engagement, and impact continue to define the future of cancer care with the report below.
